Liujing Xing, Ph.D., concentrates her practice on U.S. and foreign patent prosecution, portfolio development, and strategic client counseling in the pharmaceutical and biotechnology fields.
She has managed global patent portfolios and prosecuted patent applications involving diverse technologies, including antibodies, small molecules, gene editing, protein therapeutics, stem cell therapies, and molecular sequencing and diagnostics. Liujing also has extensive experience with due diligence, freedom-to-operate analyses, patentability analyses, and patent landscape review.
